Industry NewsPlasma-Based Companion Diagnostic Assay for Targeted Immuno-Oncology Drug Candidate Bemarituzumab
Industry NewsLiquid Biopsy Assay Assesses Microsatellite Instability Status to Identify Patients that will Benefit from Immuno-Oncology Treatment
Industry NewsNew Genomic Analysis Technology Has Been Used to Demonstrate How Cancer Drug Resistance Evolves
Industry NewsPersonal Genome Diagnostics Collaborates on Study Uncovering New Actionable Mutations and Prognostic Predictors in Pancreatic Cancer.
Product NewsPersonal Genome Diagnostics Raises $2.8 Million and Launches its METDetect Assay to Detect MET Gene Amplifications from Circulating Tumor DNA
Product NewsPersonal Genome Diagnostics Licences Technology from Johns Hopkins University for Improved Detection of Cancer Mutations in Circulating DNA
Product NewsPersonal Genome Diagnostics and Blueprint Medicines Collaborate to Identify Novel Kinase Cancer Targets
